• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

Grand Challenges Annual Meeting 2023

8-11 October 2023

Dakar, Senegal

The annual Grand Challenges meeting that brings together funding and research partners throughout the Grand Challenges network and beyond. 

Session

The evolving role of pathogen genomics in public health surveillance

The role of genomics in cholera control

Date: Tuesday, 10 October
Time: 15:30 – 17:30

Session Chair: Natsuko Imai, Senior Research Manager, Disease Tracking, Wellcome
Session Chair: Supriya Kumar, Senior Program Officer, Bill & Melinda Gates Foundation

State of global cholera transmission
Nick Thomson, Head of Parasites and Microbes Programme and Group Leader, Wellcome Sanger Institute
Cholera transmission in southern Africa
Mirriam Nyenje, Public Health Institute of Malawi
Metadata standards for cholera genomics
Josefina Campos, Senior Technical Advisor to the International Pathogen Surveillance Network, WHO hub for Pandemic and Epidemic Intelligence
Panel Moderator: Sofonias Tessema, Program Lead, Pathogen Genomics, Africa CDC
Speakers:
–Samuel Kariuki, Eastern Africa Director, DNDi
-Eduardo Samo Gudo, Director-General, INS Moçambique
-Josefina Campos, Senior Technical Advisor to the International Pathogen Surveillance Network, WHO hub for Pandemic and Epidemic Intelligence
-Antoine Abou Fayad, Assistant Professor, American University of Beirut

Joint session: Advancing drug discovery for global health / Applying a translational lens to global health

Drug discovery & development opportunities at the host-pathogen interface for NTDs

Date: Wednesday, 11 October
Time: 10:45 – 12:45

Session facilitator: Gang Liu, Senior Program Officer, Bill & Melinda Gates Foundation

Session facilitator: Gary Means, Senior Program Officer, Bill & Melinda Gates Foundation

Session facilitator: Charles Mowbray, Discovery Director, DNDi

Introduction
Charles Mowbray, Discovery Director, DNDi
AI guided drug re-purposing of HDTs for Dengue
Dan Smith, Lead Data Scientist, BenevolentAI
Reverting granuloma formation in female genital schistosomiasis (FGS)
Sabine Specht, Head of Filarial Disease Program, DNDi
Chagas disease: Exploring HDT to achieve parasitological cure and limit pathology caused by a chronic infection with T. cruzi
Walderez Dutra, Professor of Cell Biology Dept. Morphology, Institute of Biological Sciences Federal University of Minas Gerais
Approaches to tackle complicated forms of cutaneous leishmaniasis through HDTs
Maria Adelaida Gómez, Coordinator of Molecular Biology and Biochemistry Leishmaniasis Research Program, Approaches to tackle complicated forms of cutaneous leishmaniasis through HDTs Rationale for the different approaches and compounds in the pipeline, Centro Internacional de Entrenamiento e Investigaciones Medicas – CIDEIM

More information

  • Event website

AI & New Tech Drug discovery Chagas disease Dengue

Other events

Loading...
20 May 2025

Geneva, Switzerland

Strengthening the global ecosystem for paediatric medicines: leadership, collaboration, and impact

21 May 2025

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

7-10 May 2025

Amsterdam, The Netherlands

EASL Congress 2025

20-25 May 2025

Iguaçu Falls, Brazil

22nd ISHAM Congress

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License